Public Market Listing
6990HKEX
Live quotes, historical charts, and market capitalization for Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(6 total)
6Total Assets
0Approved
1Phase 3 / Filed
5Phase 1–2 / Early
4Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Phase 3 | PD-L1Monoclonal antibody | Non-Small Cell Lung CancerBreast Cancer HR+/HER2- Metastatic Breast Cancer | |
| Phase 2 | EGFR x c-METAntibody–drug conjugate | Non-Small Cell Lung Cancer | |
| Phase 2 | TSLPMonoclonal antibody | Chronic Obstructive Pulmonary DiseaseAsthma | |
| Phase 1/2 | RETSmall molecule | Non-Small Cell Lung Cancer | |
| Phase 1/2 | RETSmall molecule | Non-Small Cell Lung Cancer | |
| Phase 1 | Undisclosed / early pipelineMultispecific antibody | Asthma |
Upcoming events
Research
Unlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Research
Unlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.